Lupin seems to have broken out of it's consolidation after tracing an Elongated Flat correction. In the long term, it seems to be a good long.
Longer time frame. Decent risk reward ratio of 3x. LUPIN seems to be settling above 200DMA and the next resistance is at 1878. It should reach there in a month or so.
As per the observations, it has made a breakout from downward trending line on daily charts and also building a bull flag pattern. I would be expecting a breakout from current levels to reach target of 1850 levels. Target 1: 1760 Target 2: 1800 Target 3: 1850 Stoploss: 1720
Auro Pharma seems to be starting a healthly uptrend. It's under consolidation now. Going long upon the upper trendline break could be a good idea. The safest entry would be on the break of the topmost trendline.
Extremely favourable risk reward trade. Stoploss at 503, just above 200 week moving average. Extremely important level for any stock. It has broken the resistance level of 500 and may soon breach 100 DMA. First target is 540 and second target is 576. This trade does derive comfort from the general breakout of pharma sector in India.
Will look to enter a long position depending on price action
Stock insanely undervalued with Belviq and a great board! Biotechs tend to perform well in bear markets. I will create a google drive for company models, so that everyone has access. 1.50 is a great price to buy more if you are already in this GL www.tradingsignalreviews.com
After long consolidation, it has broken to the upside with high buying volume. Target: 494 SL 470
CRMD saw a massive gain yesterday. Over the course of the day we can see that the MACD historam tightens with the stock price into a triangle - suggesting a probably trend continuation (though reversal is also possible). A major break through this formation on substantial volume will indicate whether CRMD could potentially see a second big day, or if it will...
PMC recently revised its 2016 forecast downward - sending its share price tumbling. From there the stock has been trending more or less sideways (there its little data since the drop to form a between 22 and 23 with volume declining. This suggests a major move north or south is called for - which we got just recently. Volume has picked up slightly on that move...
Symmetrical triangle and channel breakouts indicate possible long entry here.
As per the Elliot Wave, 5 waves correction has been completed and now I expect three upward corrective waves before the its bearish downtrend resumes in its direction. Risk/Reward: 1:5 Target: 609-616 Stoploss: 571-580
As per Elliot Wave, 5 wave correction has been completed at 580 levels and now I expect to see 3 corrective waves before it continues on to its downtrend. Markets in all indices show similar charts, and I believe the markets are ready for a short term corrective upward move. Risk Reward: 1:5 Target 1: 609-620 Stop Loss:570
The has been absolutely no fundamental change to this bio company that has multiple big pharma partners. Yet due to the overall biotech downturn NASDAQ:PIRS was hit pretty hard. This presents a true 10 bagger opportunity , and Im not even remotely stretching the truth. The technicals show you why right now is the PERFECT time to buy. A little due diligence will...